Index RUT
P/E -
EPS (ttm) -0.36
Insider Own 35.62%
Shs Outstand 12.29M
Perf Week 4.72%
Market Cap 145.85M
Forward P/E 13.57
EPS next Y 0.87
Insider Trans -23.80%
Shs Float 7.99M
Perf Month -18.40%
Income -4.25M
PEG -
EPS next Q 0.15
Inst Own 40.11%
Short Float 7.81%
Perf Quarter -29.47%
Sales 35.20M
P/S 4.14
EPS this Y 29.12%
Inst Trans 48.89%
Short Ratio 3.25
Perf Half Y -53.56%
Book/sh 0.77
P/B 15.30
EPS next Y 21.89%
ROA -15.16%
Short Interest 0.62M
Perf Year 8.90%
Cash/sh 0.46
P/C 25.81
EPS next 5Y -
ROE -52.70%
52W Range 8.44 - 34.85
Perf YTD -22.75%
Dividend Est. -
P/FCF 56.10
EPS past 5Y 18.02%
ROI -25.82%
52W High -66.28%
Beta 1.37
Dividend TTM -
Quick Ratio 1.05
Sales past 5Y 29.81%
Gross Margin 79.32%
52W Low 39.22%
ATR (14) 1.10
Dividend Ex-Date -
Current Ratio 1.05
EPS Y/Y TTM 28.88%
Oper. Margin -9.27%
RSI (14) 41.42
Volatility 7.54% 9.02%
Employees 117
Debt/Eq 0.77
Sales Y/Y TTM 12.41%
Profit Margin -12.08%
Recom 1.00
Target Price 26.40
Option/Short Yes / Yes
LT Debt/Eq 0.75
EPS Q/Q -168.57%
Payout -
Rel Volume 0.66
Prev Close 12.18
Sales Surprise -0.17%
EPS Surprise 1.41%
Sales Q/Q 23.55%
Earnings Mar 12 AMC
Avg Volume 192.01K
Price 11.75
SMA20 -3.40%
SMA50 -23.62%
SMA200 -41.86%
Trades
Volume 127,847
Change -3.53%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-07-25 Initiated
Needham
Buy
$25
Jun-21-24 Initiated
ROTH MKM
Buy
$25
Aug-12-21 Downgrade
Maxim Group
Buy → Hold
Jun-07-21 Initiated
H.C. Wainwright
Buy
$28
Feb-08-21 Initiated
Maxim Group
Buy
$36
Mar-25-25 09:50AM
Mar-24-25 09:30AM
Mar-21-25 06:00PM
Mar-20-25 06:15PM
Mar-16-25 10:57AM
07:20PM
Loading…
Mar-13-25 07:20PM
03:08AM
Mar-12-25 05:15PM
04:15PM
(Associated Press Finance)
04:01PM
Mar-06-25 09:30AM
Mar-05-25 08:30AM
Mar-04-25 08:30AM
Feb-28-25 06:00PM
Feb-26-25 08:30AM
06:00PM
Loading…
Feb-11-25 06:00PM
Feb-05-25 06:00PM
08:30AM
Feb-04-25 08:00AM
Jan-29-25 06:00PM
Jan-28-25 06:15PM
Jan-24-25 09:30AM
Jan-22-25 06:15PM
Jan-13-25 06:15PM
Jan-07-25 08:11AM
Dec-23-24 09:40AM
08:15AM
Dec-17-24 08:30AM
Dec-06-24 09:40AM
Dec-05-24 06:00AM
04:01PM
Loading…
Dec-04-24 04:01PM
Nov-27-24 09:30AM
Nov-26-24 12:00PM
08:48AM
Nov-25-24 09:35AM
Nov-21-24 12:20PM
Nov-20-24 09:55AM
09:40AM
Nov-08-24 08:01AM
Nov-07-24 05:25PM
04:15PM
(Associated Press Finance)
04:01PM
09:35AM
09:30AM
08:00AM
Nov-06-24 07:41AM
Nov-04-24 09:40AM
Nov-01-24 06:00PM
Oct-30-24 08:30AM
Oct-25-24 06:00PM
Oct-24-24 06:15PM
08:30AM
Oct-16-24 06:15PM
09:40AM
Oct-10-24 06:15PM
Oct-05-24 10:35AM
Oct-01-24 06:15PM
Sep-30-24 06:00AM
Sep-26-24 08:30AM
Sep-24-24 06:15PM
Sep-18-24 09:40AM
Sep-16-24 06:15PM
Sep-13-24 12:43PM
Sep-04-24 08:30AM
Aug-23-24 09:30AM
Aug-16-24 09:40AM
Aug-14-24 11:41AM
Aug-09-24 09:30AM
Aug-08-24 09:55AM
Aug-07-24 08:30AM
Jul-31-24 12:20PM
Jul-26-24 08:30AM
Jul-25-24 05:35PM
04:36PM
(Associated Press Finance)
04:11PM
04:01PM
Jul-23-24 11:39AM
Jul-18-24 10:01AM
Jul-16-24 06:15PM
10:00AM
08:30AM
Jul-09-24 06:15PM
08:30AM
Jun-26-24 08:38AM
08:34AM
Jun-25-24 08:30AM
Jun-19-24 09:40AM
Jun-17-24 06:00PM
03:12PM
Jun-15-24 02:51AM
Jun-03-24 09:40AM
08:50AM
May-20-24 09:30AM
May-17-24 08:50AM
May-10-24 07:30AM
May-07-24 10:00AM
May-06-24 12:00PM
May-02-24 11:50AM
11:50AM
09:30AM
AudioEye, Inc. engages in the provision of digital accessibility technology solutions. It offers patented, Internet content publication and distribution software which enables the conversion of any media into an accessible format and allowing real-time distribution to end-users on any Internet connected device. The company was founded by Nathaniel T. Bradley, Sean D. Bradley, David J. Ide, and James G. Crawford on May 20, 2005 and is headquartered in Tucson, AZ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
HAWKINS JAMES B Director Mar 19 '25 Buy 15.39 13,300 204,750 114,382 Mar 21 04:33 PM Tahir Jamil A. Director Dec 04 '24 Sale 24.00 125,000 3,000,000 195,000 Dec 06 04:02 PM Moradi David CHIEF EXECUTIVE OFFICER Dec 04 '24 Sale 24.00 900,000 21,600,000 1,864,290 Dec 06 04:02 PM Bettis Carr EXEC CHRMN/CHRMN OF THE BOARD Dec 04 '24 Sale 24.00 225,000 5,400,000 200,045 Dec 06 04:01 PM Georgevich Kelly CHIEF FINANCIAL OFFICER Nov 12 '24 Sale 29.00 10,000 290,000 88,981 Nov 14 05:49 PM Georgevich Kelly CHIEF FINANCIAL OFFICER Nov 14 '24 Sale 27.00 500 13,500 88,481 Nov 14 05:49 PM Moradi David CHIEF EXECUTIVE OFFICER Nov 12 '24 Sale 29.48 68,298 2,013,696 2,830,035 Nov 14 05:47 PM Moradi David CHIEF EXECUTIVE OFFICER Nov 13 '24 Sale 26.82 51,684 1,386,034 2,778,351 Nov 14 05:47 PM Moradi David CHIEF EXECUTIVE OFFICER Nov 14 '24 Sale 26.14 14,061 367,495 2,764,290 Nov 14 05:47 PM David Moradi Officer Nov 12 '24 Proposed Sale 33.64 300,000 10,092,000 Nov 12 06:10 PM KELLY GEORGEVICH Officer Nov 12 '24 Proposed Sale 33.64 20,000 672,800 Nov 12 05:36 PM Bettis Carr EXEC CHRMN/CHRMN OF THE BOARD Jun 12 '24 Sale 20.46 7,330 149,994 425,045 Jun 14 04:06 PM Fleming Katherine E. Director Jun 12 '24 Buy 20.46 7,330 149,994 23,461 Jun 14 04:06 PM
Index RUT
P/E 26.22
EPS (ttm) 7.78
Insider Own 6.48%
Shs Outstand 16.75M
Perf Week 5.84%
Market Cap 3.43B
Forward P/E 20.02
EPS next Y 10.19
Insider Trans -9.69%
Shs Float 15.71M
Perf Month 1.39%
Income 134.48M
PEG 2.28
EPS next Q 2.40
Inst Own 110.29%
Short Float 12.07%
Perf Quarter 16.41%
Sales 1.65B
P/S 2.08
EPS this Y 13.97%
Inst Trans 11.27%
Short Ratio 7.43
Perf Half Y 40.13%
Book/sh 49.32
P/B 4.13
EPS next Y 9.93%
ROA 6.97%
Short Interest 1.90M
Perf Year 48.62%
Cash/sh 6.05
P/C 33.71
EPS next 5Y 11.51%
ROE 16.85%
52W Range 126.57 - 220.00
Perf YTD 21.79%
Dividend Est. -
P/FCF -
EPS past 5Y 16.36%
ROI 10.25%
52W High -7.31%
Beta 1.19
Dividend TTM -
Quick Ratio 1.25
Sales past 5Y 5.71%
Gross Margin 31.19%
52W Low 61.11%
ATR (14) 8.55
Dividend Ex-Date -
Current Ratio 1.88
EPS Y/Y TTM 17.89%
Oper. Margin 12.97%
RSI (14) 58.47
Volatility 3.53% 4.46%
Employees 6681
Debt/Eq 0.90
Sales Y/Y TTM 20.69%
Profit Margin 8.15%
Recom 1.29
Target Price 221.43
Option/Short Yes / Yes
LT Debt/Eq 0.59
EPS Q/Q 5.06%
Payout 0.00%
Rel Volume 0.71
Prev Close 203.32
Sales Surprise 3.25%
EPS Surprise 3.86%
Sales Q/Q 12.48%
Earnings Jan 23 BMO
Avg Volume 255.31K
Price 203.92
SMA20 6.34%
SMA50 5.42%
SMA200 26.72%
Trades
Volume 181,116
Change 0.30%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-21-25 Initiated
JP Morgan
Neutral
$225
Jan-24-25 Reiterated
B. Riley Securities
Buy
$180 → $221
Sep-30-24 Initiated
BofA Securities
Buy
$175
Sep-18-24 Initiated
Wells Fargo
Overweight
$170
Jul-27-21 Initiated
Imperial Capital
Outperform
$140
Dec-10-20 Initiated
Oppenheimer
Outperform
$110
Nov-13-20 Initiated
Berenberg
Buy
$103
Aug-24-18 Reiterated
B. Riley FBR
Buy
$81 → $92.50
Jun-21-18 Downgrade
Sidoti
Buy → Neutral
Feb-02-18 Downgrade
Jefferies
Buy → Hold
Aug-25-17 Reiterated
Jefferies
Buy
$85 → $93
May-24-17 Initiated
Sidoti
Buy
Apr-12-17 Initiated
Jefferies
Buy
$86
Nov-16-16 Initiated
Drexel Hamilton
Buy
Aug-17-16 Reiterated
The Benchmark Company
Buy
$65 → $70
Jun-21-16 Upgrade
The Benchmark Company
Hold → Buy
$65
Jun-14-16 Initiated
CJS Securities
Market Outperform
Apr-28-16 Downgrade
The Benchmark Company
Buy → Hold
$75 → $65
Apr-13-16 Reiterated
The Benchmark Company
Buy
$83 → $75
Jan-28-16 Reiterated
The Benchmark Company
Buy
$102 → $83
Show Previous Ratings
Mar-21-25 06:06PM
Mar-19-25 08:30AM
Mar-18-25 05:04AM
Mar-17-25 05:04AM
Mar-14-25 11:50AM
05:06AM
Loading…
Mar-12-25 05:06AM
Mar-10-25 08:30AM
Feb-24-25 08:30AM
Feb-16-25 02:44PM
Feb-05-25 08:30AM
08:03AM
08:01AM
Jan-29-25 08:30AM
Jan-28-25 08:05AM
08:02AM
08:02AM
Loading…
Jan-27-25 08:02AM
Jan-26-25 08:01AM
Jan-24-25 12:00PM
03:08AM
(Thomson Reuters StreetEvents)
02:06AM
Jan-23-25 01:05PM
12:44PM
10:30AM
09:40AM
08:46AM
08:37AM
(Associated Press Finance)
08:30AM
Jan-22-25 08:02AM
07:06AM
Jan-20-25 09:15AM
08:30AM
Loading…
Jan-16-25 08:30AM
04:04AM
Jan-15-25 08:30AM
Jan-13-25 06:30PM
08:30AM
Jan-10-25 04:01AM
Jan-08-25 08:30AM
Jan-06-25 08:30AM
Dec-10-24 05:10AM
Dec-06-24 03:15AM
Dec-05-24 05:00PM
Dec-04-24 02:06AM
Dec-02-24 06:33AM
Nov-28-24 04:38AM
Nov-27-24 03:09AM
Nov-26-24 04:27AM
Nov-20-24 08:30AM
Nov-18-24 02:01AM
Nov-06-24 02:18AM
02:12AM
Oct-31-24 08:30AM
Oct-30-24 08:30AM
03:05AM
03:01AM
Oct-29-24 03:18PM
09:35AM
Oct-28-24 03:17AM
Oct-25-24 05:01AM
Oct-24-24 11:00AM
09:40AM
09:23AM
08:40AM
(Associated Press Finance)
08:39AM
08:30AM
Oct-23-24 09:07AM
03:09AM
Oct-21-24 04:04AM
04:02AM
Oct-18-24 04:36AM
Oct-17-24 10:01AM
08:30AM
Oct-09-24 03:59AM
Oct-08-24 08:30AM
Sep-26-24 08:30AM
Sep-25-24 04:54AM
Sep-19-24 08:30AM
Sep-16-24 05:08AM
Sep-11-24 03:43AM
Sep-10-24 07:26AM
Sep-09-24 03:42AM
Sep-04-24 09:55AM
08:30AM
Aug-26-24 12:00PM
Aug-23-24 03:43AM
(Thomson Reuters StreetEvents)
Aug-22-24 11:48AM
10:30AM
10:10AM
09:16AM
(Associated Press Finance)
09:08AM
09:00AM
Aug-21-24 03:01AM
Aug-19-24 09:15AM
Aug-15-24 08:30AM
Jul-29-24 08:30AM
Jul-17-24 10:25AM
Jul-16-24 10:11PM
07:00AM
03:38AM
Jul-09-24 12:27PM
08:30AM
OSI Systems, Inc. engages in the design and manufacture of specialized electronic systems, and components for critical applications. It operates through the following segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment includes security inspection systems and related services, and turnkey security screening solutions. The Healthcare segment provides patient monitoring, diagnostic cardiology, and related services. The Optoelectronics and Manufacturing segment refers to electronic components and electronic manufacturing services. The company was founded by Deepak Chopra in May 1987 and is headquartered in Hawthorne, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
CHOPRA DEEPAK EXECUTIVE CHAIRMAN Feb 04 '25 Sale 198.26 20,000 3,965,200 364,478 Feb 05 02:42 PM CHOPRA DEEPAK EXECUTIVE CHAIRMAN Feb 03 '25 Sale 193.55 20,000 3,871,000 384,478 Feb 05 02:42 PM DEEPAK CHOPRA Officer Feb 04 '25 Proposed Sale 198.26 20,000 3,965,210 Feb 04 04:36 PM CHOPRA FAMILY TRUST U/A DTD 12 Officer Feb 03 '25 Proposed Sale 196.44 20,000 3,928,800 Feb 03 04:18 PM Morben Paul Keith PRES., OSI ELECTRONICS Jan 30 '25 Sale 199.36 155 30,901 10,077 Jan 31 10:55 AM PAUL MORBEN Officer Jan 30 '25 Proposed Sale 199.36 155 30,901 Jan 30 04:01 PM CHIZEVER GERALD M Director Jan 27 '25 Sale 195.83 2,701 528,937 5,000 Jan 27 05:28 PM CHIZEVER GERALD M Director Jan 27 '25 Proposed Sale 195.83 2,701 528,940 Jan 27 01:31 PM EDRICK ALAN I EVP & CFO Dec 13 '24 Sale 188.00 7,646 1,437,448 304,798 Dec 13 05:40 PM EDRICK ALAN I EVP & CFO Dec 12 '24 Sale 188.42 2,354 443,541 312,444 Dec 13 05:40 PM CHOPRA DEEPAK PRESIDENT AND CEO Dec 12 '24 Sale 187.66 20,000 3,753,200 404,323 Dec 13 05:31 PM ALIABADI MANOOCHER M PRES., OPTOELECTRONICS DIV Dec 13 '24 Sale 180.02 2,509 451,670 78,094 Dec 13 05:29 PM MANOOCHER MANSOURI-ALIABADI Officer Dec 13 '24 Proposed Sale 180.02 2,509 451,676 Dec 13 04:41 PM ALAN EDRICK Officer Dec 13 '24 Proposed Sale 188.00 7,646 1,437,448 Dec 13 04:23 PM DEEPAK CHOPRA Officer Dec 12 '24 Proposed Sale 187.66 20,000 3,753,280 Dec 12 05:07 PM HAWKINS JAMES B Director Dec 10 '24 Sale 182.62 2,000 365,240 6,396 Dec 12 04:43 PM ALAN EDRICK Officer Dec 12 '24 Proposed Sale 188.42 2,354 443,547 Dec 12 04:43 PM Ballhaus William Francis JR Director Dec 10 '24 Sale 181.63 675 122,600 26,516 Dec 12 04:42 PM BALLHAUS TRUST Director Dec 10 '24 Proposed Sale 181.63 675 122,598 Dec 10 04:36 PM JAMES HAWKINS Director Dec 10 '24 Proposed Sale 182.62 2,000 365,249 Dec 10 04:05 PM ALIABADI MANOOCHER M PRES., OPTOELECTRONICS DIV Dec 04 '24 Sale 180.39 1,728 311,714 80,603 Dec 06 08:09 AM MANOOCHER MANSOURI-ALIABADI Officer Dec 04 '24 Proposed Sale 180.39 1,728 311,713 Dec 04 05:00 PM CHOPRA DEEPAK PRESIDENT AND CEO Nov 12 '24 Sale 153.87 20,000 3,077,400 424,323 Nov 13 06:00 PM CHOPRA DEEPAK PRESIDENT AND CEO Nov 11 '24 Sale 153.42 15,000 2,301,250 0 Nov 13 06:00 PM CHOPRA 2012 IRREVOCABLE TRUST spouse Nov 11 '24 Proposed Sale 153.47 5,000 767,326 Nov 12 08:49 AM THE DEEPIKA CHOPRA TRUST Officer Nov 11 '24 Proposed Sale 153.39 10,000 1,533,882 Nov 12 08:47 AM CHIZEVER GERALD M Director Nov 07 '24 Sale 148.16 2,000 296,320 7,701 Nov 12 08:18 AM CHIZEVER GERALD M Director Nov 07 '24 Proposed Sale 148.16 2,000 296,322 Nov 07 05:37 PM CHOPRA DEEPAK PRESIDENT AND CEO Sep 16 '24 Sale 144.92 20,000 2,898,400 459,033 Sep 17 05:00 PM CHOPRA FAMILY TRUST U/A DTD 12 Officer Sep 16 '24 Proposed Sale 145.39 40,000 5,815,600 Sep 16 04:35 PM Morben Paul Keith PRES., OSI ELECTRONICS Sep 13 '24 Sale 145.04 1,107 160,559 10,077 Sep 13 09:55 PM CHIZEVER GERALD M Director Sep 11 '24 Sale 138.41 3,000 415,230 3,462 Sep 13 05:00 PM PAUL MORBEN Officer Sep 13 '24 Proposed Sale 145.04 1,107 160,562 Sep 13 04:08 PM CHIZEVER GERALD M Director Sep 11 '24 Proposed Sale 138.41 3,000 415,224 Sep 11 09:10 PM Chandra Shalabh PRES., SPACELABS HEALTHCARE Jun 12 '24 Sale 139.50 676 94,302 8,192 Jun 14 11:00 AM EDRICK ALAN I EVP & CFO Jun 03 '24 Sale 143.75 30,386 4,368,084 310,529 Jun 05 09:00 PM EDRICK ALAN I EVP & CFO Jun 05 '24 Sale 142.54 13,696 1,952,228 296,833 Jun 05 09:00 PM EDRICK ALAN I EVP & CFO May 28 '24 Sale 142.14 4,216 599,262 340,915 May 29 05:30 PM ALIABADI MANOOCHER M PRES., OPTOELECTRONICS DIV May 21 '24 Sale 143.58 2,567 368,570 81,473 May 22 09:00 PM CHOPRA DEEPAK PRESIDENT AND CEO May 15 '24 Sale 139.75 40,000 5,589,823 428,615 May 17 09:00 PM Ballhaus William Francis JR Director May 08 '24 Sale 133.98 675 90,436 25,907 May 09 06:29 PM CHIZEVER GERALD M Director May 08 '24 Sale 134.11 3,000 402,330 10,515 May 09 06:26 PM HAWKINS JAMES B Director May 08 '24 Sale 134.09 10,000 1,340,875 7,834 May 09 06:16 PM LUSKIN MEYER/ Director Apr 29 '24 Sale 134.36 6,755 907,587 20,883 May 01 05:30 PM LUSKIN MEYER/ Director Apr 30 '24 Sale 130.76 5,000 653,800 15,883 May 01 05:30 PM Morben Paul Keith PRES., OSI ELECTRONICS Apr 30 '24 Sale 133.02 310 41,236 8,834 May 01 03:25 PM
Index RUT
P/E 35.18
EPS (ttm) 1.51
Insider Own 36.91%
Shs Outstand 12.71M
Perf Week 1.75%
Market Cap 673.39M
Forward P/E 26.28
EPS next Y 2.02
Insider Trans -0.11%
Shs Float 8.02M
Perf Month -3.95%
Income 19.23M
PEG -
EPS next Q 0.41
Inst Own 55.18%
Short Float 2.51%
Perf Quarter -0.73%
Sales 73.24M
P/S 9.19
EPS this Y 5.42%
Inst Trans 2.58%
Short Ratio 5.10
Perf Half Y 10.38%
Book/sh 6.83
P/B 7.75
EPS next Y 15.14%
ROA 20.20%
Short Interest 0.20M
Perf Year 18.98%
Cash/sh 4.11
P/C 12.89
EPS next 5Y -
ROE 24.31%
52W Range 40.18 - 63.29
Perf YTD -3.71%
Dividend Est. -
P/FCF 38.22
EPS past 5Y 13.91%
ROI 22.15%
52W High -16.32%
Beta 0.83
Dividend TTM 0.62 (1.17%)
Quick Ratio 7.62
Sales past 5Y 15.27%
Gross Margin 76.94%
52W Low 31.81%
ATR (14) 1.51
Dividend Ex-Date Feb 24, 2025
Current Ratio 8.84
EPS Y/Y TTM 11.28%
Oper. Margin 29.99%
RSI (14) 44.45
Volatility 2.08% 2.75%
Employees 160
Debt/Eq 0.00
Sales Y/Y TTM 11.71%
Profit Margin 26.26%
Recom 1.00
Target Price 71.00
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q 12.74%
Payout 29.91%
Rel Volume 0.69
Prev Close 52.86
Sales Surprise 1.51%
EPS Surprise 0.00%
Sales Q/Q 11.10%
Earnings Feb 13 BMO
Avg Volume 39.42K
Price 52.96
SMA20 0.26%
SMA50 -6.15%
SMA200 4.15%
Trades
Volume 27,431
Change 0.19%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-12-23 Initiated
Lake Street
Buy
$50
Oct-31-17 Resumed
ROTH Capital
Buy
Oct-05-16 Downgrade
ROTH Capital
Buy → Neutral
Nov-02-15 Reiterated
ROTH Capital
Buy
$25 → $30
Jul-30-15 Reiterated
ROTH Capital
Buy
$23 → $25
Jun-16-15 Reiterated
ROTH Capital
Buy
$19 → $23
Jan-12-15 Reiterated
ROTH Capital
Buy
$15 → $18
Dec-23-14 Reiterated
ROTH Capital
Buy
$12 → $15
Mar-10-25 08:30AM
Feb-14-25 04:53AM
(Thomson Reuters StreetEvents)
02:19AM
Feb-13-25 09:45AM
08:40AM
(Associated Press Finance)
08:30AM
Loading…
08:30AM
Feb-12-25 07:40AM
Jan-30-25 08:30AM
Jan-10-25 08:30AM
Dec-19-24 08:30AM
Dec-10-24 08:30AM
Nov-04-24 08:30AM
Nov-01-24 03:16AM
Oct-31-24 09:25AM
08:20AM
(Associated Press Finance)
08:00AM
Loading…
08:00AM
Oct-30-24 09:16AM
Oct-24-24 04:05PM
Oct-09-24 03:52PM
Oct-03-24 04:05PM
Oct-01-24 04:05PM
(Investor's Business Daily)
Sep-30-24 08:01AM
Sep-10-24 04:30PM
Aug-01-24 09:50AM
09:29AM
08:44AM
(Associated Press Finance)
Jul-25-24 08:30AM
Jun-07-24 08:30AM
May-06-24 09:39AM
May-02-24 12:53PM
09:54AM
Loading…
09:54AM
08:41AM
(Associated Press Finance)
08:30AM
Apr-25-24 04:05PM
Mar-13-24 04:30PM
Feb-19-24 10:18AM
Feb-09-24 09:55AM
Feb-08-24 08:38AM
08:26AM
(Associated Press Finance)
08:05AM
Feb-01-24 04:05PM
Jan-09-24 08:30AM
Jan-02-24 04:30PM
Dec-16-23 01:01AM
Dec-12-23 10:00AM
Dec-06-23 11:06AM
Nov-30-23 09:00AM
Nov-14-23 03:03AM
Nov-05-23 09:23AM
Nov-03-23 09:45AM
08:10AM
(Associated Press Finance)
08:00AM
Oct-26-23 04:05PM
Sep-25-23 08:38AM
Sep-13-23 09:10PM
Sep-11-23 05:00AM
Sep-06-23 04:00PM
Aug-30-23 08:50AM
Aug-24-23 05:00AM
Aug-23-23 07:48AM
Aug-11-23 08:50AM
Aug-03-23 09:25AM
08:19AM
08:00AM
Jul-31-23 07:49AM
Jul-27-23 08:45AM
Jun-29-23 11:07AM
Jun-27-23 08:50AM
Jun-15-23 10:51AM
Jun-08-23 08:50AM
May-18-23 08:50AM
May-16-23 09:19AM
May-10-23 08:30AM
May-04-23 09:55AM
08:44AM
08:30AM
Apr-27-23 08:30AM
Apr-17-23 12:41PM
Mar-27-23 12:04PM
Mar-15-23 08:21AM
Mar-06-23 08:45AM
Feb-27-23 08:27AM
Feb-24-23 04:15PM
Feb-20-23 06:02AM
Feb-06-23 01:29PM
(American City Business Journals)
09:02AM
Feb-02-23 09:15AM
08:00AM
Jan-26-23 10:30AM
Jan-25-23 12:45PM
Jan-20-23 09:54AM
Jan-18-23 08:00AM
Jan-06-23 09:18AM
Dec-07-22 06:08AM
Nov-29-22 12:45PM
08:55AM
Nov-09-22 06:39AM
Nov-07-22 12:57PM
Nov-03-22 10:15AM
07:00AM
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GLENN JOHN Officer Dec 02 '24 Proposed Sale 54.18 2,500 135,445 Jan 06 04:07 PM GLENN JOHN CHIEF FINANCIAL OFFICER Dec 02 '24 Sale 54.18 2,500 135,449 4,383 Dec 02 09:00 PM VUOTO ANTHONY Director Nov 06 '24 Sale 55.99 2,690 150,616 14,234 Nov 06 04:15 PM VUOTO ANTHONY Director Nov 06 '24 Proposed Sale 55.99 2,690 150,616 Nov 06 12:14 PM ALLEN MONTY K Director Jun 03 '24 Sale 43.37 1,947 84,432 18,053 Jun 04 05:15 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite